Skip to content

Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome.

Evaluation of Pain, Hand Function, Electrophysiological and Ultrasonographic Effects When Comparing 5% Dextrose Saline Injection Via Nerve Hydrodissection Under Ultrasound Guidance in Mild to Moderate Carpal Tunnel Syndrome.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07524933
Enrollment
96
Registered
2026-04-13
Start date
2026-01-08
Completion date
2026-07-10
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conditions

Brief summary

Comparison of the effectiveness of nerve hydrodissection with saline injection of 5% dextrose in carpal tunnel syndrome.

Detailed description

Evaluation of pain, hand function, electrophysiological and ultrasonographic effects when comparing 5% dextrose saline injection via nerve hydrodissection under ultrasound guidance in mild to moderate carpal tunnel syndrome.

Interventions

DRUGNerve Hydrodissection with 5% Dextrose

Injection therapy

Sponsors

Antalya Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-80 years * Clinical and electrophysiological diagnosis of mild to moderate carpal tunnel syndrome * Symptom duration of at least 3 months * Both male and female participants * Patients who have not responded adequately to conservative treatment * Patients who do not wish to undergo surgical treatment * Ability to provide informed consent

Exclusion criteria

* Severe or very severe carpal tunnel syndrome based on EMG findings * Previous injection therapy for carpal tunnel syndrome * Prior wrist or carpal tunnel surgery * Polyneuropathy or other peripheral neuropathies * Cervical radiculopathy or proximal median nerve entrapment * Brachial plexopathy or thoracic outlet syndrome * Pregnancy * Malignancy * Local or systemic infection * Cognitive impairment affecting cooperation * Systemic diseases affecting the median nerve (e.g., uncontrolled diabetes mellitus, thyroid disorders)

Design outcomes

Primary

MeasureTime frameDescription
Change in pain intensity measured by Visual Analog Scale (VAS)Baseline to 8 monthThe primary outcome is the change in pain intensity assessed by the Visual Analog Scale (VAS, 0-10). The difference between baseline and follow-up scores will be analyzed.

Secondary

MeasureTime frameDescription
Change in Qucik DASH scoreBaseline to 8 monthAssessed using symptom severity and functional status scales
Change in median nerve cross-sectional areaBaseline to 8 monthMeasured at the carpal tunnel inlet using ultrasonography
hange in nerve conduction study parametersBaseline to 8 monthDistal motor latency and sensory conduction velocity of the median nerve
Change in hand grip strengthBaseline to 8 monthStrength of the arm

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026